Rising demand for novel drugs and pharmaceuticals and advancements in drug delivery technologies are estimated to bolster pharmaceutical excipients market growth. Growing investments in the development of novel drugs and pharmaceuticals will also create new opportunities for pharmaceutical excipients companies in the long run. Surging demand for generic drugs is also expected to create new opportunities for pharmaceutical excipients companies in the long run. Increasing pharmaceutical manufacturing activity around the world is also forecasted to bolster market development across the study period and beyond.
Global Pharmaceutical Excipients Market size was valued at USD 9.1 billion in 2023 and is poised to grow from USD 9.63 billion in 2024 to USD 15.12 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).
Growing sales of biologics is also expected to uplift the demand for novel pharmaceutical excipients in the future. On the contrary, high costs of manufacturing, stringent regulations, fluctuations in raw material supply, and competition from other alternative products are slated to impede Pharmaceutical Excipients market growth over the coming years. North America and the Asia Pacific region are estimated to remain the key markets for all pharmaceutical excipients companies.
Get a Free Sample PDF of the Report – http://www.skyquestt.com/sample-request/pharmaceutical-excipients-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Pharmaceutical Excipients Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Pharmaceutical Excipients Market is segmented by Product Type, Functionality, Formulation, Source, End User and region.
Based on Product Type, the market is segmented into Organic Chemicals, Inorganic Chemicals and Others.
Based on Functionality, the market is segmented into Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants, Preservatives, Flavors and Sweeteners, Coloring Agents, Solvents and Others.
Based on Formulation, the market is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations, Inhalation Formulations, Ophthalmic Formulations, Nasal Formulations and Suppositories.
Based on Source, the market is segmented into Natural and Synthetic.
Based on End User, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs).
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Pharmaceutical Excipients Market – Regional Analysis:
North America is estimated to lead the global pharmaceutical excipients demand outlook. Presence of key pharmaceutical excipients manufacturers, high demand for pharmaceuticals, and robust spending on medical research are key factors helping the dominance of this region. Rising popularity of biologics and generic drugs to reduce healthcare costs in this region is also expected to create new opportunities for pharmaceutical excipients companies in the future.
The Asia Pacific region is emerging as the fastest-growing market for pharmaceutical excipient companies in the world. Growing investments in healthcare infrastructure development and rapidly increasing geriatric population are contributing to high demand for pharmaceutical excipients in this region. Rising healthcare expenditure and growing pharmaceutical manufacturing are also estimated to create new opportunities for pharmaceutical excipients companies in this region. India, China, and Japan are the most opportune countries for pharmaceutical excipients providers in the Asia Pacific region.
Top Market Players in Pharmaceutical Excipients Market are:
Evonik Industries AG – Germany
Ashland Global Holdings Inc. – USA
International Flavors & Fragrances Inc. – USA
Roquette Freres – France
Fuji Chemical Industries Co., Ltd. – Japan
Wacker Chemie AG – Germany
MEGGLE GmbH & Co. KG – Germany
Biogrund GmbH – Germany
Nitika Pharmaceutical Specialties Pvt. Ltd. – India
J.M. Huber Corporation – USA
Kerry Group plc – Ireland
Colorcon Inc. – USA
Merck KGaA – Germany
DFE Pharma – Germany
Finar Limited – India
Corel Pharma Chem – India
Gattefosse – France
BASF SE – Germany
DowDuPont Inc. – USA
Recent Developments:
In October 2023, a new range of pharmaceutical excipients was launched at the CPHI Barcelona event by Clariant, a renowned chemicals company. VitiPure® excipients were aimed at solving the challenges of bioavailability of active pharmaceutical ingredients for pharmaceutical manufacturers.
In November 2021, three new pharmaceutical excipients were launched by Gattefossé, a leading provider of pharmaceutical excipients. Labrafac MC60, Gelucire 59/14 and Emulfree Duo were launched after they cleared all regulatory requirements and helped the company strengthen its stance in the global Pharmaceutical Excipients market.
Back in July 2021, Pharmacel sMCC 90, a silicified microcrystalline cellulose (MCC) was launched by a leading pharmaceutical excipient provider known as DFE Pharma. The new excipient solution was developed for oral dosage formulations.
You may Also Like
https://medium.com/@kathan.trivedi/global-ceramics-market-trends-growth-drivers-and-future-outlook-6a4bb82e8c0e
https://insightdigits.exblog.jp/243686824/
Forward-Looking Insights
The Pharmaceutical Excipients Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
